Lancet Diabetes Endocrinol . 2022 Mar;10(3):193-206. doi: 10.1016/S2213-8587(22)00008-0. Epub 2022 Feb 4.
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Takashi Kadowaki 1, Joakim Isendahl 2, Usman Khalid 2, Sang Yeoup Lee 3, Tomoyuki Nishida 4, Wataru Ogawa 5, Kazuyuki Tobe 6, Toshimasa Yamauchi 7, Soo Lim 8, STEP 6 investigators